Cargando…
A Hallmark Clinical Study of Cord Blood Therapy in Adults with Ischemic Stroke
The therapeutic application of human umbilical cord blood cells has been an area of great interest for at least the last 25 years. Currently, cord blood cells are approved for reconstitution of the bone marrow following myeloablation in both young and old patients with myeloid malignancies and other...
Autores principales: | Sanberg, Paul R., Ehrhart, Jared |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767876/ https://www.ncbi.nlm.nih.gov/pubmed/31184206 http://dx.doi.org/10.1177/0963689719854354 |
Ejemplares similares
-
Plasma derived from human umbilical cord blood: Potential cell‐additive or cell‐substitute therapeutic for neurodegenerative diseases
por: Ehrhart, Jared, et al.
Publicado: (2018) -
Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model
por: Lee, Jea‐Young, et al.
Publicado: (2019) -
Beneficial Effects of Transplanted Human Bone Marrow Endothelial Progenitors on Functional and Cellular Components of Blood-Spinal Cord Barrier in ALS Mice
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2021) -
Commentary: Precision – The hallmark of refractive surgery
por: Singh, Aastha, et al.
Publicado: (2023) -
Autoimmunity is a hallmark of post-COVID syndrome
por: Rojas, Manuel, et al.
Publicado: (2022)